BioNavis reviewed by a leading Finnish economic newspaper

Kauppalehti, a leading economic newspaper of Finland, has published two articles about BioNavis. The first one is a review of the company development entitled “A Lesson to Technology Companies”, while the second article is an evaluation written by a senior venture capitalist Petri Niemi.

An interview with the CEO of BioNavis Ltd, Mr. Sauli Törmälä, tries to pinpoint the key actions that led the company from a VTT (Technical Research Centre of Finland) spin-off into a company serving global markets. Strengthening the sales network, introducing new automatic models (and increasing the sales volume) and especially strengthening the brand helped to bring five times higher order intake than in previous year. There are plenty of traditional Surface Plasmon Resonance (SPR) instruments on the market, but only one Multi-Parametric SPR (MP-SPR)! 

As a serial entrepreneur, Sauli Törmälä is comparing and evaluating the growth path of BioNavis with other high-tech companies, he has owned and led. The expectation is that BioNavis will grow to a 5-7 million euro company in a few years.

In his column (Kauppalehti, 28.2.201328.2.2013, 42/2013, pp. B14), Mr. Petri Niemi, has focused on the potential of BioNavis’ current SPR Navi-range products now and also on future product directions in the upcoming years. He has especially raised the value of surface material-drug interactions, which are exclusive to MP-SPR due to the instrument versatility and hence unlimited material choice. As an example, Mr. Niemi has chosen the applications in cancer-targeting drugs and diagnostics. He was impressed by the branding and bold industrial design of the instruments. He proclaims: “A well-kept secret is spreading out from the laboratories!”